Skip to main content

and
  1. Article

    Open Access

    Tumor mutational burden quantification from targeted gene panels: major advancements and challenges

    Tumor mutational burden (TMB), the total number of somatic coding mutations in a tumor, is emerging as a promising biomarker for immunotherapy response in cancer patients. TMB can be quantitated by a number of...

    Laura Fancello, Sara Gandini, Pier Giuseppe Pelicci in Journal for ImmunoTherapy of Cancer (2019)

  2. Article

    Open Access

    Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL

    Following the publication of this article, the authors noted that Dr Laura Fancello was not listed among the authors. The corrected author list is given below. Additionally, the following was not included in t...

    Kim R. Kampen, Sergey O. Sulima, Benno Verbelen, Tiziana Girardi in Leukemia (2019)